Concepedia

Song Mu

SM

Statistics

Publications

32

Citations

1.3K

H-Index

20

Active since

2013

Affiliations

Chongqing Medical University(Current)

The Affiliated Yongchuan Hospital of Chongqing Medical University

Novartis (Switzerland)

Novartis (United States)

Southern Medical University

Song Mu is an author at Chongqing Medical University specializing in medicine, pharmacology, and radiation oncology.

ORCID

Top concepts

Publications per year

2013–2024

32

Publications

32

Phase Ib Study of Panobinostat and Bortezomib in Relapsed or Relapsed and Refractory Multiple Myeloma

Jesús F. San Miguel, Paul G. Richardson, Andreas Günther et al. · Journal of Clinical Oncology · 2013 · 144 citations · Full text

The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer

Youqin Xu, Song Mu, Ziyang Hong et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 122 citations · Full text

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Michael Friedländer, Tarek Meniawy, Ben Markman et al. · The Lancet Oncology · 2019 · 113 citations

, , +6

Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma.

Weimin Zhao, Song Mu, Jie Zhang et al. · PubMed · 2015 · 110 citations · Full text

, , +18

Lentivirus-mediated overexpression of OTULIN ameliorates microglia activation and neuroinflammation by depressing the activation of the NF-κB signaling pathway in cerebral ischemia/reperfusion rats

Hongbei Xu, Wenyi Qin, Hu Xiao et al. · Journal of Neuroinflammation · 2018 · 61 citations · Full text

1–5 of 32